MPZL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.346000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.678400E-01
Normal-vs-Stage2
1.662630E-01
Normal-vs-Stage3
5.166800E-01
Normal-vs-Stage4
1.345390E-01
Stage1-vs-Stage2
3.010200E-01
Stage1-vs-Stage3
6.710800E-01
Stage1-vs-Stage4
1.455970E-01
Stage2-vs-Stage3
8.110400E-01
Stage2-vs-Stage4
4.675200E-01
Stage3-vs-Stage4
5.552200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.815600E-01
Normal-vs-AfricanAmerican
5.026100E-02
Normal-vs-Asian
1.577180E-01
Caucasian-vs-AfricanAmerican
3.337700E-02
Caucasian-vs-Asian
1.399200E-01
AfricanAmerican-vs-Asian
4.356200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.622200E-01
Normal-vs-Female
2.198600E-01
Male-vs-Female
8.422400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.464400E-01
Normal-vs-Age(41-60Yrs)
9.193600E-02
Normal-vs-Age(61-80Yrs)
3.318800E-01
Normal-vs-Age(81-100Yrs)
2.534800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.243900E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.865400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.916250E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.401800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.432790E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.795000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.599400E-01
Normal-vs-Daily Drinker
6.892800E-01
Normal-vs-Weekly Drinker
1.981190E-01
Normal-vs-Occasional Drinker
3.551000E-01
Normal-vs-Social Drinker
1.980040E-01
Non Drinker-vs-Daily Drinker
1.914180E-01
Non Drinker-vs-Weekly Drinker
5.331200E-01
Non Drinker-vs-Occasional Drinker
9.337000E-01
Non Drinker-vs-Social Drinker
7.339400E-01
Daily Drinker-vs-Weekly Drinker
6.953900E-02
Daily Drinker-vs-Occasional Drinker
2.456600E-01
Daily Drinker-vs-Social Drinker
1.038590E-01
Weekly Drinker-vs-Occasional Drinker
4.921400E-01
Weekly Drinker-vs-Social Drinker
7.528600E-01
Occasional Drinker-vs-Social Drinker
6.733800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.587000E-01
Normal-vs-Grade 2
5.575700E-03
Normal-vs-Grade 3
2.399700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.343400E-03
Grade 1-vs-Grade 3
1.353570E-02
Grade 1-vs-Grade 4
2.587000E-01
Grade 2-vs-Grade 3
3.754000E-01
Grade 2-vs-Grade 4
5.575700E-03
Grade 3-vs-Grade 4
2.399700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.569600E-01
Normal-vs-NonDiabetic
2.359000E-01
Diabetic-vs-NonDiabetic
2.205800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.873600E-01
Normal-vs-NoPancreatitis
2.928400E-01
Pancreatitis-vs-NoPancreatitis
3.896000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.814400E-01
Normal-vs-N1
1.873180E-01
N0-vs-N1
7.459400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.665980E-01
Normal-vs-TP53-NonMutant
4.639800E-01
TP53-Mutant-vs-TP53-NonMutant
7.290200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
